Radionetics Oncology
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
More and more biotech companies are exploring the potential of biologic drugs produced inside bioreactors by microbial and mammalian cells. But culturing or fermenting these cells and monitoring experiments can be a huge and costly headache. Culture Biosciences runs a cloud-based bioreactor lab where clients can schedule bioreactor time, submit organisms and materials, and monitor and analyze experimental data without having to build or operate their own facilities.
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing
Using self-supervised machine learning to map the circuit diagram of tumor biology and develop new immunotherapies for cancer
Advancing precision medicine by combining the efficacy of antibodies with the binding ability of small molecules